OSN presents cover stories for cataract surgeons
Click Here to Manage Email Alerts
Since the start of 2019, Ocular Surgery News has brought issues of interest to cataract surgeons to the front page. Here are five cover stories that delve into OCT and IOL technologies, steroid options, managing patient expectations, and new drugs and protocols:
Retinal OCT before cataract surgery increasingly helps guide treatment choices
Screening the retina with OCT rules out preexisting conditions that would affect the outcomes of cataract surgery and helps select candidates for premium IOLs. Read more.
New frontiers in IOL technology aim at flexible, customized solutions
Despite decades of trying to optimize results and despite the many advances in IOL technology, achieving optimal refractive outcomes and meeting patient expectations with cataract surgery are still challenges. Results are subject to many variables, and looking at statistics, only about half of patients are within the high satisfaction range of achieving 0.5 D of emmetropia and 0.5 D or less of astigmatism. Read more.
New steroid options allow surgeons to better tailor postoperative treatment
With four new steroid options on the market to treat pain and inflammation after ocular surgery, ophthalmologists can now better tailor their postoperative regimens for their individual patients. Read more.
Cataract surgeons address needs, expectations of aging patients after refractive procedures
More than 30 years have passed since the first PRK procedures were performed, followed by LASIK a few years later. An increasing number of keratorefractive patients are now old enough to have visually significant cataract, and surgeons need to be prepared to approach them and deal with their specific requirements and expectations. Read more.
New drugs, protocols reduce pain and inflammation associated with cataract surgery
Drugs, better surgical techniques and new technologies can limit the amount of pain and inflammation a patient experiences after undergoing cataract surgery. Read more.